MB
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Harmonizing neuropsychological assessment for mild neurocognitive disorders in Europe | Alzheimer's & dementia |  | 2022 | 288 | 123 | ||
| Diagnostic value of amyloid-PET and tau-PET: a head-to-head comparison | European Journal of Nuclear Medicine and Molecular Imaging | | 2021 | 278 | 134 | ||
| The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers | European journal of nuclear medicine and molecular imaging | | 2021 | 171 | 104 | ||
| 2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework | European journal of nuclear medicine and molecular imaging | | 2021 | 182 | 111 | ||
| The strategic biomarker roadmap for the validation of Alzheimer's diagnostic biomarkers: methodological update | European Journal of Nuclear Medicine and Molecular Imaging | | 2021 | 273 | 122 | ||
| Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer's disease | European Journal of Nuclear Medicine and Molecular Imaging |  | 2020 | 367 | 6 | ||
| The A/T/N model applied through imaging biomarkers in a memory clinic | European Journal of Nuclear Medicine and Molecular Imaging | | 2019 | 372 | 6 | ||
| Progress update from the hippocampal subfields group | Alzheimer's & dementia | | 2019 | 297 | 170 | ||
| Medial temporal lobe atrophy and posterior atrophy scales normative values | NeuroImage: Clinical | | 2019 | 459 | 201 | ||
| Assessment of longitudinal hippocampal atrophy in the first year after ischemic stroke using automatic segmentation techniques | NeuroImage: Clinical | | 2019 | 254 | 170 | ||
| A comparison of automated segmentation and manual tracing in estimating hippocampal volume in ischemic stroke and healthy control participants | NeuroImage: Clinical | | 2018 | 410 | 244 | ||
| Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia | European Journal of Nuclear Medicine and Molecular Imaging | | 2018 | 418 | 0 | ||
| European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18 F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus | European Journal of Neurology | | 2018 | 343 | 2 | ||
| Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington's disease | European Journal of Nuclear Medicine and Molecular Imaging | | 2018 | 415 | 0 | ||
| Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia | European Journal of Nuclear Medicine and Molecular Imaging | | 2018 | 400 | 0 | ||
| Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders | European Journal of Nuclear Medicine and Molecular Imaging | | 2018 | 320 | 0 | ||
| Clinical utility of FDG PET in Parkinson's disease and atypical parkinsonism associated with dementia | European Journal of Nuclear Medicine and Molecular Imaging | | 2018 | 457 | 176 | ||
| Quantitative appraisal of the Amyloid Imaging Taskforce appropriate use criteria for amyloid-PET | Alzheimer's & Dementia | | 2018 | 411 | 0 | ||
| Clinical utility of FDG-PET for the clinical diagnosis in MCI | European Journal of Nuclear Medicine and Molecular Imaging | | 2018 | 403 | 0 | ||
| Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer's disease | European Journal of Nuclear Medicine and Molecular Imaging | | 2018 | 398 | 0 | ||
| L'atrophie du lobe temporal mésial détectée par IRM en tant que biomarqueur de la maladie d'Alzheimer | Revue médicale suisse | | 2018 | 880 | 1,095 | ||
| Abnormalities in functional connectivity in borderline personality disorder: Correlations with metacognition and emotion dysregulation | Psychiatry Research: Neuroimaging | | 2018 | 442 | 1 | ||
| Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia | European Journal of Nuclear Medicine and Molecular Imaging | | 2018 | 384 | 170 | ||
| AMYPAD Diagnostic and Patient Management Study: Rationale and design | Alzheimer's & Dementia | | 2018 | 413 | 274 | ||
| The biomarker-based diagnosis of Alzheimer's disease. 1-ethical and societal issues | Neurobiology of aging | | 2017 | 467 | 7 | ||
| The biomarker-based diagnosis of Alzheimer's disease. 2-lessons from oncology | Neurobiology of Aging | | 2017 | 486 | 2 | ||
| Clinical validity of medial temporal atrophy as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework | Neurobiology of Aging | | 2017 | 381 | 0 | ||
| Clinical validity of delayed recall tests as a gateway biomarker for Alzheimer's disease in the context of a structured 5-phase development framework | Neurobiology of Aging | | 2017 | 397 | 0 | ||
| Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework | Neurobiology of aging | | 2017 | 439 | 1 | ||
| Biomarkers for the diagnosis of Alzheimer's disease in clinical practice: an Italian intersocietal roadmap | Neurobiology of aging | | 2017 | 465 | 1 | ||
| Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework | Neurobiology of aging | | 2017 | 490 | 0 | ||
| Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers | The Lancet Neurology | | 2017 | 622 | 7 | ||
| Clinical validity of cerebrospinal fluid Aβ42, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework | Neurobiology of Aging | | 2017 | 411 | 0 | ||
| A harmonized segmentation protocol for hippocampal and parahippocampal subregions: Why do we need one and what are the key goals? | Hippocampus | | 2017 | 364 | 145 | ||
| Reference standard space hippocampus labels according to the European Alzheimer's Disease Consortium-Alzheimer's Disease Neuroimaging Initiative harmonized protocol: Utility in automated volumetry | Alzheimer's & Dementia | | 2017 | 364 | 0 | ||
| Clinical validity of presynaptic dopaminergic imaging with 123I-ioflupane and noradrenergic imaging with 123I-MIBG | Neurobiology of Aging | | 2017 | 344 | 0 | ||
| Integrating longitudinal information in hippocampal volume measurements for the early detection of Alzheimer's disease | NeuroImage | | 2016 | 645 | 4 | ||
| Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly | Neurobiology of aging | | 2016 | 662 | 3 | ||
| Do Beliefs about the Pathogenetic Role of Amyloid Affect the Interpretation of Amyloid PET in the Clinic | Neurodegenerative Diseases | | 2016 | 391 | 1 | ||
| MRI for Pre-Dementia Trials | The Journal of Prevention of Alzheimer's Disease | | 2016 | 299 | 0 | ||
| Assessment of the Incremental Diagnostic Value of Florbetapir F 18 Imaging in Patients With Cognitive Impairment: The Incremental Diagnostic Value of Amyloid PET With [18F]-Florbetapir (INDIA-FBP) Study | JAMA neurology | | 2016 | 429 | 2 | ||
| Automated hippocampal segmentation in 3D MRI using random undersampling with boosting algorithm | Pattern Analysis and Application | | 2016 | 359 | 157 | ||
| Occipital sources of resting-state alpha rhythms are related to local gray matter density in subjects with amnesic mild cognitive impairment and Alzheimer's disease | Neurobiology of Aging | | 2015 | 315 | 0 | ||
| Delphi definition of the EADC-ADNI Harmonized Protocol for hippocampal segmentation on magnetic resonance | Alzheimer's & dementia | | 2015 | 560 | 3 | ||
| Training labels for hippocampal segmentation based on the EADC-ADNI harmonized hippocampal protocol | Alzheimer's & dementia | | 2015 | 597 | 2 | ||
| The EADC-ADNI Harmonized Protocol for manual hippocampal segmentation on magnetic resonance: Evidence of validity | Alzheimer's & dementia | | 2015 | 587 | 2 | ||
| Hippocampal and amygdalar local structural differences in elderly patients with schizophrenia | The American journal of geriatric psychiatry | | 2015 | 472 | 0 | ||
| Relationship between hippocampal atrophy and neuropathology markers: a 7T MRI validation study of the EADC-ADNI Harmonized Hippocampal Segmentation Protocol | Alzheimer's & dementia | | 2015 | 532 | 3 | ||
| Harmonized benchmark labels of the hippocampus on magnetic resonance: The EADC-ADNI project | Alzheimer's & dementia | | 2015 | 578 | 1 | ||
| Manual segmentation qualification platform for the EADC-ADNI harmonized protocol for hippocampal segmentation project | Alzheimer's & dementia | | 2015 | 586 | 4 | ||
| Operationalizing protocol differences for EADC-ADNI manual hippocampal segmentation | Alzheimer's & dementia | | 2015 | 456 | 0 | ||
| Abnormalities in cortical gray matter density in borderline personality disorder | European psychiatry | | 2015 | 526 | 3 | ||
| Multiple RF classifier for the hippocampus segmentation: Method and validation on EADC-ADNI Harmonized Hippocampal Protocol | Physica Medica | | 2015 | 374 | 171 | ||
| Medial temporal atrophy in early and late-onset Alzheimer's disease | Neurobiology of aging | | 2014 | 473 | 2 | ||
| Impact of alcohol consumption in healthy adults: a magnetic resonance imaging investigation | Psychiatry Research | | 2014 | 354 | 0 | ||
| Establishing magnetic resonance images orientation for the EADC-ADNI manual hippocampal segmentation protocol | Journal of Neuroimaging | | 2014 | 362 | 0 | ||
| Coalition Against Major Diseases/European Medicines Agency biomarker qualification of hippocampal volume for enrichment of clinical trials in predementia stages of Alzheimer's disease | Alzheimer's & dementia | | 2014 | 491 | 1 | ||
| Atypical nucleus accumbens morphology in psychopathy: another limbic piece in the puzzle | International Journal of Law and Psychiatry | | 2013 | 324 | 0 | ||
| Structural brain features of borderline personality and bipolar disorders | Psychiatry Research | | 2013 | 373 | 0 | ||
| Striatal morphology in early-onset and late-onset Alzheimer's disease: a preliminary study | Neurobiology of Aging | | 2013 | 356 | 0 | ||
| Norms for imaging markers of brain reserve | Journal of Alzheimer's Disease | | 2012 | 396 | 0 | ||
| Volumetric and topographic differences in hippocampal subdivisions in borderline personality and bipolar disorders | Psychiatry research. Neuroimaging | | 2012 | 610 | 0 | ||
| Hippocampal and amygdalar volume changes in elderly patients with Alzheimer's disease and schizophrenia | Psychiatry research | | 2011 | 599 | 0 | ||
| Survey of protocols for the manual segmentation of the hippocampus: preparatory steps towards a joint EADC-ADNI harmonized protocol | Journal of Alzheimer's Disease | | 2011 | 362 | 0 | ||
| Cortex and amygdala morphology in psychopathy | Psychiatry Research | | 2011 | 516 | 1 | ||
| Local amygdala structural differences with 3T MRI in patients with Alzheimer disease | Neurology | | 2011 | 333 | 0 | ||
| The CST3 B haplotype is associated with frontotemporal lobar degeneration | European Journal of Neurology | | 2010 | 235 | 0 | ||
| Abnormal hippocampal shape in offenders with psychopathy | Human Brain Mapping | | 2010 | 329 | 0 | ||
| Clinical and medial temporal features in a family with mood disorders | Neuroscience Letters | | 2010 | 347 | 0 | ||
| H1 haplotype of the MAPT gene is associated with lower regional gray matter volume in healthy carriers | European Journal of Human Genetics | | 2009 | 350 | 0 | ||
| HOXA1 A218G polymorphism is associated with smaller cerebellar volume in healthy humans | Journal of Neuroimaging | | 2009 | 338 | 0 | ||
| White-matter lesions along the cholinergic tracts are related to cortical sources of EEG rhythms in amnesic mild cognitive impairment | Human Brain Mapping | | 2009 | 326 | 0 | ||
| Alexithymia in healthy women: a brain morphology study | Journal of Affective Disorders | | 2009 | 334 | 1 | ||
| The Italian Brain Normative Archive of structural MR scans: norms for medial temporal atrophy and white matter lesions | Aging Clinical and Experimental Research | | 2009 | 330 | 0 | ||
| Effect of the XbaI polymorphism of estrogen receptor alpha on postmenopausal gray matter | Neuroscience Letters | | 2008 | 349 | 0 | ||
| Hippocampal shape differences in dementia with Lewy bodies | NeuroImage | | 2008 | 285 | 0 | ||
| Effects of hormone therapy on brain morphology of healthy postmenopausal women: a Voxel-based morphometry study | Menopause | | 2006 | 360 | 1 | ||
| The effect of apolipoprotein polymorphism on brain in mild cognitive impairment: a voxel-based morphometric study | Dementia and Geriatric Cognitive Disorders | | 2006 | 399 | 0 | ||
| Topographic correspondence between white matter hyperintensities and brain atrophy | Journal of Neurology | | 2006 | 360 | 0 | ||
| Influence of serotonin receptor 2A His452Tyr polymorphism on brain temporal structures: a volumetric MR study | European Journal of Human Genetics | | 2006 | 332 | 0 | ||
| Cognitive rehabilitation for severe dementia: critical observations for better use of existing knowledge | Mechanisms of Ageing and Development | | 2006 | 324 | 0 | ||
| Effects of estrogens on cognition and brain morphology: involvement of the cerebellum | Maturitas | | 2006 | 326 | 0 | ||
| Frontotemporal dementia as a neural system disease | Neurobiology of Aging | | 2005 | 324 | 0 | ||
| APOE and modulation of Alzheimer's and frontotemporal dementia | Neuroscience Letters | | 2004 | 285 | 0 | ||
| The MRI pattern of frontal and temporal brain atrophy in fronto-temporal dementia | Neurobiology of Aging | | 2003 | 327 | 0 | ||
| Clinical characteristics of frontotemporal patients with symmetric brain atrophy | European Archives of Psychiatry and Clinical Neuroscience | | 2002 | 332 | 0 | ||
| Amygdaloid atrophy in frontotemporal dementia and Alzheimer's disease | Neuroscience Letters | | 2002 | 355 | 1 |
